Balyasny Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-110,983
| Closed | -$892K | – | 1998 |
|
|
2025
Q1 | $892K | Buy |
110,983
+63,471
| +134% | +$510K | ﹤0.01% | 1394 |
|
|
2024
Q4 | $427K | Buy |
+47,512
| New | +$427K | ﹤0.01% | 1524 |
|
|
2024
Q2 | – | Sell |
-288,875
| Closed | -$1.45M | – | 1921 |
|
|
2024
Q1 | $1.45M | Sell |
288,875
-598,139
| -67% | -$3M | ﹤0.01% | 1167 |
|
|
2023
Q4 | $7.97M | Buy |
887,014
+624,186
| +237% | +$5.61M | 0.02% | 681 |
|
|
2023
Q3 | $2.04M | Sell |
262,828
-542,706
| -67% | -$4.22M | ﹤0.01% | 992 |
|
|
2023
Q2 | $7.8M | Sell |
805,534
-506,813
| -39% | -$4.91M | 0.02% | 667 |
|
|
2023
Q1 | $14.4M | Buy |
1,312,347
+852,516
| +185% | +$9.34M | 0.04% | 503 |
|
|
2022
Q4 | $1.99M | Sell |
459,831
-393,956
| -46% | -$1.7M | 0.01% | 1073 |
|
|
2022
Q3 | $6.42M | Buy |
853,787
+354,536
| +71% | +$2.67M | 0.02% | 688 |
|
|
2022
Q2 | $5.02M | Sell |
499,251
-43,351
| -8% | -$436K | 0.02% | 752 |
|
|
2022
Q1 | $6.72M | Buy |
+542,602
| New | +$6.72M | 0.02% | 661 |
|
|
2018
Q1 | – | Sell |
-500,000
| Closed | -$2.27M | – | 1728 |
|
|
2017
Q4 | $2.27M | Hold |
500,000
| – | – | 0.01% | 889 |
|
|
2017
Q3 | $3.14M | Hold |
500,000
| – | – | 0.01% | 699 |
|
|
2017
Q2 | $3.07M | Buy |
500,000
+200,000
| +67% | +$1.23M | 0.01% | 698 |
|
|
2017
Q1 | $2.2M | Buy |
+300,000
| New | +$2.2M | 0.01% | 742 |
|